ethyl pyruvate has been researched along with Hemorrhagic Shock in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dieteren, S; Franz, N; Marzi, I; Mörs, K; Perl, M; Relja, B; Schmidt, J; Wagner, N | 1 |
Dieteren, S; Franz, N; Köhler, K; Marzi, I; Mörs, K; Nicin, L; Perl, M; Relja, B; Schmidt, J; Wagner, N | 1 |
Brunner, M; Cai, B; Deitch, EA; Ulloa, L; Wang, H; Wang, P | 1 |
Mongan, PD; Sharma, P | 1 |
Cotton, BA | 1 |
Fink, MP | 2 |
3 review(s) available for ethyl pyruvate and Hemorrhagic Shock
Article | Year |
---|---|
Alternative fluids for prehospital resuscitation: "pharmacological" resuscitation fluids.
Topics: Adjuvants, Immunologic; Animals; Dehydroepiandrosterone; Emergency Medical Services; Enzyme Inhibitors; Fluid Therapy; Humans; Oxidative Stress; Pyruvates; Resuscitation; Shock, Hemorrhagic; Treatment Outcome; Valproic Acid; Wounds and Injuries | 2011 |
Ethyl pyruvate.
Topics: Anti-Inflammatory Agents; Humans; Neuroprotective Agents; Pancreatitis; Pyruvates; Reperfusion Injury; Sepsis; Shock, Hemorrhagic; Shock, Septic | 2008 |
Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution.
Topics: Adult; Animals; Critical Care; Disease Models, Animal; Humans; Isotonic Solutions; Multiple Organ Failure; NF-kappa B; Pyruvates; Reactive Oxygen Species; Respiratory Distress Syndrome; Resuscitation; Sepsis; Shock, Hemorrhagic | 2002 |
4 other study(ies) available for ethyl pyruvate and Hemorrhagic Shock
Article | Year |
---|---|
Ethyl pyruvate reduces acute lung damage following trauma and hemorrhagic shock via inhibition of NF-κB and HMGB1.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Gene Expression Regulation; HMGB1 Protein; Humans; Lung; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Pyruvates; Rats; Rats, Inbred Lew; Shock, Hemorrhagic; Signal Transduction; Thoracic Injuries; Tumor Necrosis Factor-alpha | 2018 |
Ethyl pyruvate ameliorates hepatic injury following blunt chest trauma and hemorrhagic shock by reducing local inflammation, NF-kappaB activation and HMGB1 release.
Topics: Animals; Female; HMGB1 Protein; Inflammation; Liver; NF-kappa B; Pyruvates; Rats; Rats, Inbred Lew; Shock, Hemorrhagic; Thoracic Injuries; Wounds, Nonpenetrating | 2018 |
Ethyl pyruvate improves survival in awake hemorrhage.
Topics: Anesthesia; Animals; Consciousness; Cytokines; Enzyme-Linked Immunosorbent Assay; Liver; Lung; Male; Myocardium; NF-kappa B; Poly(ADP-ribose) Polymerases; Pyruvates; Rats; Rats, Sprague-Dawley; Resuscitation; Shock, Hemorrhagic; Spleen; Survival Rate; Treatment Outcome; Tumor Necrosis Factor-alpha; Wakefulness | 2009 |
Hypertonic sodium pyruvate solution is more effective than Ringer's ethyl pyruvate in the treatment of hemorrhagic shock.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Caspase 3; Cytokines; Fluid Therapy; Hepatitis; Hypertonic Solutions; Isotonic Solutions; Lipid Peroxidation; Liver; Male; Oxidative Stress; Pyruvates; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Resuscitation; Ringer's Lactate; Shock, Hemorrhagic | 2010 |